期刊文献+

紫杉醇涂层球囊物理性能的测试方案

Test Plan for Physical Properties of Drug Coated Balloons
下载PDF
导出
摘要 目的:确定药物涂层球囊的物理检测范围,确定紫杉醇带药球囊的物理性能,建立测试方法。方法:依据行业标准YY0285.4-2017《血管内导管一次性使用无菌导管第4部分:球囊扩张导管》,结合药物球囊的特性对球囊额定爆破压、球囊疲劳、球囊充盈及泄压时间、球囊与压力关系等测试方向进行分析考察并明确性能判定。结果:提出药物涂层球囊产品的物理性能测试方案,为同类产品的球囊力学检测提供技术支持。结论:药物涂层球囊的力学检测要结合常规球囊的方法综合考虑分析其临床应用,以符合标准规定要求及判定。 Objective:Determine the physical detection range of drug coated balloons,determine the physical properties of paclitaxel loaded balloons,and establish testing methods.Methods:Based on the industry standard YY0285.4-2017 Sterile Catheters for Single Use Intravascular Catheters-Part 4:Balloon Dilation Catheters,combined with the characteristics of drug balloons,the rated burst pressure,balloon fatigue,balloon filling and pressure relief time,and the relationship between balloons and pressure were analyzed and evaluated,and the basic performance judgment was clarified.Results:A physical performance testing plan for drug coated balloon products was proposed,providing technical support for mechanical testing of similar products.Conclusion:The mechanical testing of drug coated balloons should be combined with conventional balloon methods to comprehensively consider and analyze their clinical application,in order to meet the requirements and judgments of standard regulations.
作者 崔红 胡志伟 焦永哲 李沅 CUI Hong;HU Zhi-wei;JIAO Yong-zhe;LI Yuan(Tianjin Medical Device Quality Supervision and Testing Center,Tianjin 300384)
出处 《中国医疗器械信息》 2023年第19期47-50,共4页 China Medical Device Information
关键词 药物涂层球囊 物理 检测标准 测试方案 drug coated balloon physics testing standards test plan
  • 相关文献

参考文献9

二级参考文献63

  • 1陆飞,程云章.医疗器械临床试验实施过程质量管理探讨[J].中国食品药品监管,2010(10):66-69. 被引量:3
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2155
  • 3杨新春,张大鹏,王乐丰,徐立,葛永贵,王红石,李惟铭,倪祝华,夏昆,连勇,薛永利,马利祥.冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J].中华心血管病杂志,2007,35(6):517-522. 被引量:74
  • 4Maisel W H.Unanswered questions-drug-eluting stents and the risk of late thrombosis[J].New England Journal of Medicine,2007(356):981-984.
  • 5Lemos P A,Hoye A,Goedhart D,et al.Clinical,angiographic,and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients--An evaluation from the rapamycin-eluting stent evaluated at rotterdam cardiology hospital(RESEARCH)study[J].Circulation,2004(109):1366-1370.
  • 6Iofina E,Langenberg R,Blindt R,et al.Polymer-based paclitaxel-eluting stents are superior to nonpolymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions[J].The American Journal of Cardiology,2006(98):1022-1027.
  • 7vander Giessen W J,Lincoff A M,Schwartz R S,et al.Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries[J].Circulation,1996(94):1690-1697.
  • 8Scheller B,Speck U,Abramjuk C,et al.Paclitaxel balloon coating,a novel method for prevention and therapy of restenosis[J].Circulation,2004(110):810-814.
  • 9Kirtane A J,Gupta A,Iyengar S.Safety and efficacy of drug-eluting and bare metal stents comprehensive metaanalysis of randomized trials and observational studies[J].Circulation,2009(119):3196-3198.
  • 10Radke P W,Joner M,Joost A.Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model:the importance of excipients[J].Eurointervention,2011(7):730-737.

共引文献1742

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部